TIMP2 and acute kidney injury: In the Sapphire study [184], combined TIMP2 and IGFBP7 measurement demonstrated an excellent ability to predict moderate to severe AKI, and it was superior to all the other existing AKI markers, considerably improving patient risk stratification [185,186].